June 09, 2015
Actavis PLC and other pharmaceutical companies were hit with a proposed class action in New York federal court Monday over an alleged scheme to delay generic versions of the Alzheimer's drug Namenda, days after Actavis asked the Second Circuit to rethink an injunction related to the drug.